Search
Corvus Pharmaceuticals Inc
CRVSAdd to Watchlist
13.260USD
+0.070+0.53%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.12BMarket Cap
LossP/E TTM
CRVS Financials
See Corvus Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Corvus Pharmaceuticals Inc Earnings Date
Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.16
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.19
81.05%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its current assets were 58.21M, with a year-on-year change of 7.00.
What are the total assets of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its total assets of Corvus Pharmaceuticals Inc were 71.12M, with a year-on-year change of 3.21.
What are the total liabilities of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Corvus Pharmaceuticals Inc were 9.91M, with a year-on-year change of -72.72.
What is the total equity of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its total equity of Corvus Pharmaceuticals Inc was 61.20M, with a year-on-year change of 87.93.
What is the net operating income of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Corvus Pharmaceuticals Inc was -42.97M, with a year-on-year change of -55.99.
What is the net investment of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its net investment of Corvus Pharmaceuticals Inc was -7.80M, with a year-on-year change of 71.63.
What is the net financing of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its net financing of Corvus Pharmaceuticals Inc was 36.43M, with a year-on-year change of -25.70.
What is the Earnings Per Share (EPS) of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.19, with a year-on-year change of 81.05.
What is the net income of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its net income was -15.28M, with a year-on-year change of 75.47.
What is the Return on Equity (ROE) of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -32.60, with a year-on-year change of 81.36.
What is the Return on Assets (ROA) of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -21.83, with a year-on-year change of 79.95.
What is the operating profit of Corvus Pharmaceuticals Inc?
According to Corvus Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -42.97M, with a year-on-year change of -55.99.